Search results for "iron"

showing 10 items of 31116 documents

CCDC 1907945: Experimental Crystal Structure Determination

2019

Related Article: Maria-Gabriela Alexandru, Diana Visinescu, Beatrice Braun-Cula, Sergiu Shova, Francesc Lloret, Miguel Julve|2019|Dalton Trans.|48|7532|doi:10.1039/C9DT01445D

tetrakis(mu-cyano)-tetranitrato-dicyano-bis(triphenylphosphine oxide)-bis(2-(pyridin-2-yl)imidazolyl)-bis(hydrogen tris(pyrazolyl)borate)-di-iron-di-samarium acetonitrile solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 238750: Experimental Crystal Structure Determination

2005

Related Article: M.Ruben, U.Ziener, J.-M.Lehn, V.Ksenofontov, P.Gutlich, G.B.M.Vaughan|2005|Chem.-Eur.J.|11|94|doi:10.1002/chem.200400584

tetrakis(mu~2~-46-bis(22':4'4''-Terpyridine-6'-yl)-2-phenylpyrimidine)-tetra-iron(ii) chloride clathrate heptaperchlorate nitromethane unknown solvate hexahydrateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 256886: Experimental Crystal Structure Determination

2005

Related Article: L.H.Uppadine, J.-P.Gisselbrecht, N.Kyritsakas, K.Nattinen, K.Rissanen, J.-M.Lehn|2005|Chem.-Eur.J.|11|2549|doi:10.1002/chem.200401224

tetrakis(mu~2~-4-(2-Pyridylacetylhydrazino)-6-(N-(6-methyl)-2-pyridylformyl-N'-methylhydrazino)-2-phenylpyrimidine)-di-iron(ii)-di-zinc(ii) bis(tetrafluoroborate) unknown solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 781469: Experimental Crystal Structure Determination

2011

Related Article: J.Mercurol, Yanling Li, E.Pardo, O.Risset, M.Seuleiman, H.Rousseliere, R.Lescouezec, M.Julve|2010|Chem.Commun.|46|8995|doi:10.1039/c0cc02024a

tetrakis(mu~2~-Cyano-CN)-dicyano-tetrakis(bis(1-methylimidazol-2-yl) ketone-NN')-bis(tetrakis(pyrazolyl)borate-NN'N'')-di-cobalt(iii)-di-iron(ii) diperchlorate dihydrateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 255485: Experimental Crystal Structure Determination

2005

Related Article: D.Armentano, G.De Munno, F.Lloret, M.Julve|2005|CrystEngComm|7|57|doi:10.1039/b417251e

tetraphenylarsonium bis(oxalato)-(110-phenanthroline)-iron(iii) monohydrateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

Potential myocardial iron content evaluation by magnetic resonance imaging in thalassemia major patients treated with Deferoxamine or Deferiprone dur…

2003

The purpose of this study was to evaluate if the variations of heart magnetic resonance imaging in beta-thalassemia major patients treated with Deferoxamine B mesylate (DF) or Deferiprone (L1) chelation therapy is a useful tool of the indirect myocardial iron content determination. For this reason, a prospective study was carried out. Seventy-two consecutive patients with beta-thalassemia major (35 treated with DF and 37 with L1) were studied. The main outcome results were laboratory parameters including determination of the liver iron concentration (LIC) and magnetic resonance imaging (MRI) of the heart and liver. The heart to muscle signal intensity ratios (HSIRs) were significantly incre…

thalassemia majormyocardial iron content
researchProduct

Role of hypogonadism in development of bone alterations in thalassemic patients

2005

Although transfusions and chelation therapy have improved survival of patients afflicted with Thalassemia Major (TM), endocrine alterations are still common complications. Particularly, hypogonadism plays an important role in the aetiology of osteoporosis in these patients. It is clear that in most patients the gonadal failure is a consequence of a pituitary damage and that a hypogonadotropic hypogonadism occurs; nevertheless, also a gonadal damage because of iron deposition may be a further cause of hypogonadism. Prevalence of the pubertal failure ranges between 50 to 80% of the cases. In some studies ferritin levels have been correlated with hypogonadism, suggesting that improvement of ch…

thalassemia hypogonadism osteoporosis iron overl
researchProduct

Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe and effective in patients with hemoglobinopathies.

2017

thalassemiaHCVthalassemia HCV iron overloadiron overload
researchProduct

Decompressive Craniectomy Improves QTc Interval in Traumatic Brain Injury Patients

2020

Background: Traumatic brain injury (TBI) is commonly associated with cardiac dysfunction, which may be reflected by abnormal electrocardiograms (ECG) and/or contractility. TBI-related cardiac disorders depend on the type of cerebral injury, the region of brain damage and the severity of the intracranial hypertension. Decompressive craniectomy (DC) is commonly used to reduce intra-cranial hypertension (ICH). Although DC decreases ICH rapidly, its effect on ECG has not been systematically studied. The aim of this study was to analyze the changes in ECG in patients undergoing DC. Methods: Adult patients without previously known cardiac diseases treated for isolated TBI with DC were studied. EC…

the index of cardio-electrophysiological balanceAdultMalemedicine.medical_specialtyDecompressive CraniectomyAdolescentIntracranial PressureTraumatic brain injuryHealth Toxicology and Mutagenesismedicine.medical_treatmentelectrocardiographylcsh:MedicineBrain damage030204 cardiovascular system & hematologyQT intervalArticleContractility03 medical and health sciencesQRS complexYoung Adult0302 clinical medicineInternal medicineBrain Injuries TraumaticmedicineHumanscardiovascular diseasesCardiac disordersmedicine.diagnostic_testbusiness.industrytraumatic brain injurylcsh:RPublic Health Environmental and Occupational Healthcardiac disordersArrhythmias CardiacMiddle Agedmedicine.diseaseTreatment Outcomecardiac arrhythmiasCardiologycardiovascular systemDecompressive craniectomyFemalemedicine.symptomIntracranial HypertensionbusinessElectrocardiography030217 neurology & neurosurgeryInternational Journal of Environmental Research and Public Health
researchProduct

El impacto del cambio climático en la movilidad humana : las migraciones climáticas en el contexto internacional y europeo

2021

For decades, the migration phenomenon has been one of the thorniest regulatory issues in the European Union (EU) policy. In addition, today, the fight against climate change in all regions of the world makes the situation worse for the new ?climate refugees? or ?environmental displaced people?, whose legal status is not yet covered by the ancient 1951 Refugee Convention.

the migration phenomenon has been one of the thorniest regulatory issues in the European Union (EU) policy. In addition:CIENCIAS JURÍDICAS [UNESCO]política climática europeathe fight against climate change in all regions of the world makes the situation worse for the new ?climate refugees? or ?environmental displaced people?Karla D. For decadespolítica migratoria europeaclimate refugeesrefugiados climáticosSistema Europeo Común de Asilo (SECA)european climate policyenvironmental displacements 526 559UNESCO::CIENCIAS JURÍDICASeuropean migration policydesplazamientos medioambientalesEuropean Union2070-8157 22082 Revista Boliviana de Derecho 584568 2021 32 8055230 El impacto del cambio climático en la movilidad humana las migraciones climáticas en el contexto internacional y europeo Zambrano GonzáleztodayCommon European Asylum System (CEAS)whose legal status is not yet covered by the ancient 1951 Refugee Convention. Unión Europea
researchProduct